A MORBIDLY obese woman who loved fast food so much she’d eat kebabs for breakfast has swapped her fast food habit for a caveman diet, and shed an amazing 55kg.
Elora Harre, 23, from Perth, was a size 24 at her biggest thanks to a solid diet of convenience foods including pizza, burgers and kebabs every day for brekkie.
But after developing headaches and sore eyes, she discovered she was pre-diabetic as a result of her eating habits, and was forced to ditch them once and for all.
Now Elora has shrunk from a size 24 to a size 12 after swapping her greasy take away food for the paleo diet, and eating meals consisting purely of natural foods.
She’s been so successful in her transformation, that she has amassed a huge online following and has just launched her own book chronicling her journey, called The Shrinking Violet — How to Lose Weight and Get Fit the paleo Way.
The evidence supporting carbohydrate restriction, or specifically ketogenic diets in cancer remains largely indirect and speculative. Our recent perspective summarized some of the relevant evolutionary and mechanistic factors: the central theme rests with the role of the glucose-insulin axis in promoting growth and proliferation, the predominant characteristic of cancer sells. So it has been observed for some time that patients with diabetes have higher risk of cancer. Epidemiological and other kinds of studies are generally consistent with the idea although different cancers are more or less closely associated with diabetes. Drugs employed as diabetes therapy, particularly metformin, have been found to have beneficial effects in cancer as well. Metformin reduces the risk of developing cancer although the effects on mortality are not clear cut. We made the case, in our critical review that dietary carbohydrate restriction is the first line of treatment for type 2 diabetes and the best adjunct for pharmacology in type 1 diabetes.
Crohn’s disease is regarded as having no curative treatment. Previous reports on dietary therapy of Crohn’s disease indicate no major success. Case Report: Here we report a severe case of Crohn’s disease where we successfully applied the paleolithic ketogenic diet. Dietary therapy resulted in resolution of symptoms, normalized laboratory parameters as well as gradual normalization of bowel inflammation as evidenced by imaging data and normalization of intestinal permeability as shown by the polyethylene glycol (PEG 400) challenge test. The patient was able to discontinue medication within two weeks. Currently he is on the diet for 15 months and is free of symptoms as well as side effects. Conclusion: We conclude that the paleolithic ketogenic diet was feasible, effective and safe in the present case.